Double-positive maternal serum screening results for down syndrome and open neural tube defects: An indicator for fetal structural or chromosomal abnormalities and adverse obstetric outcomes

This publication has 18 references indexed in Scilit:

• Elevated second-trimester maternal serum hcg alone or in combination with elevated alpha-fetoprotein
  Published by Wolters Kluwer Health ,2001
• Second-trimester prenatal screening for Down syndrome and the relationship of maternal serum biochemical markers to pregnancy complications with adverse outcome
  Prenatal Diagnosis, 2000
• Second-trimester maternal serum marker screening: Maternal serum α-fetoprotein, β-human chorionic gonadotropin, estriol, and their various combinations as predictors of pregnancy outcome
  American Journal of Obstetrics and Gynecology, 1999
• Perinatal outcome in pregnancies with a positive serum screening for Down's syndrome due to elevated levels of free β-human chorionic gonadotropin
  Ultrasound in Obstetrics & Gynecology, 1999
• Maternal serum α-fetoprotein and dimeric inhibin A detect aneuploidies other than Down syndrome
  American Journal of Obstetrics and Gynecology, 1998
• Abnormal levels of maternal serum human chorionic gonadotropin and alpha‐fetoprotein in the second trimester: Relation to fetal weight and preterm delivery
  Prenatal Diagnosis, 1995
• Fetal karyotyping for chromosome abnormalities after an unexplained elevated maternal serum alpha-fetoprotein screening
  Obstetrics & Gynecology, 1995
• Detection of fetal Turner syndrome with multiple-marker screening
  American Journal of Obstetrics and Gynecology, 1994
• Very low maternal serum chorionic gonadotropin levels in association with fetal triploidy
  American Journal of Obstetrics and Gynecology, 1994
• Maternal serum screening for Down's syndrome in early pregnancy.
  BMJ, 1988